Mononuclear phagocytes, stimulated by bacterial lipopolysaccharide (LPSI, have been implicated in the activation of coagulation in sepsis and endotoxemia. In monocytes LPS induces the synthesis of tissue factor (TF) which, assembled with factor VII, initiates the blood coagulation cascades. In this study we investigated the mechanism of LPS recognition by monocytes, and the consequent expression of TF mRNA and TF activity. We also studied the inhibition of these effects of LPS by rBP123, a 23-kD recombinant fragment of bactericidalfpermeability increasing protein, which has been shown to antagonize LPS in vitro and in vivo. Human peripheral blood mononuclear cells, or monocytes isolated by adherence, were stimulated with Escherichia coli 0113 LPS at physiologically relevant concentrations (210 pg/mL).
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ISSUE FACTOR (W) has been recognized as an important initiator of blood coagulation in vivo'; it is constitutively expressed by a number of cell types, except those that are in direct contact with blood. However, TF expression can be induced in endothelial cells and monocytes by a variety of stimuli including bacterial lipopolysaccharide (LPS).' TF activity induced by LPS has been implicated in the pathogenesis of disseminated intravascular coagulation (DIC), which is a major complication of Gram-negative sep-
The induction of procoagulant activity (PCA) and TF activity (factor Xa generation) by LPS has recently been studied in blood mononuclear cells (PBMCS).~.~ Further, both TF mRNA expression and PCA induction by LPS have been investigated in monocytes isolated by adherence, as well as in the monocytic cell line THP-1.9"' In these studies the cells were exposed to relatively high concentrations of LPS (100 ng to 10 &I &, ) , in the presence of 7% to 10% fetal bovine serum. However, information is lacking on the mechanism of LPS recognition, and the prevention of TF induction.
Recognition of LPS by leukocytes has been shown to involve LPS-binding protein (LBP), a 60-kD glycoprotein synthesized by hepatocytes, which is present in normal plasma." LBP binds with high affinity to lipid A,I3 a highly conserved part of the LPS molecule that is responsible for In the present study we investigate the LPS-induced expression of TF in human PBMC, as well as in monocytes isolated by adherence. We found that TF induction by LPS required the presence of CD14 receptors as well as LBP or serum. TF induction was markedly inhibited by rBPIZ3 at both transcriptional and functional levels, suggesting a potential therapeutic benefit of rBP123 in Gram-negative sepsis.
MATERIALS AND METHODS

Reagents
Recombinant rBPIZ3, a 23-kD protein corresponding to the amino terminal part of human BPI, was cloned, expressed, and purified to homogeneity using standard techniques." Recombinant human LBP (rLBP) was cloned, expressed, and purified to homogeneity?" Thaumatin, an unrelated protein with similar isoelectric point and molecular size to rBPIZ3, was purified as previously described2* and used as a control. Smooth LPS was obtained from RIBI (Refined Standard Endotoxin from Escherichia coli 0113; RIBI ImmunoChem Research, Hamilton, MT). Zymosan (yeast cell wall polysaccharide), rabbit brain thromboplastin, Triton X-100, and gelatin (tissue culture tested) were purchased from Sigma Chemical CO (St Louis, MO). Ficoll-Paque was a product of Pharmacia LKB (Piscataway, NJ). 
Cell Preparation, Incubation, and Lysis
Human PBMCs were prepared from buffy coat from blood of healthy human donors by separation over Ficoll-Hypaq~e?~ The cellular composition of PBMC preparations was determined by fluorescence-activated cell sorter (FACS) analy~is.~' Based on the expression of CD14 antigen, the preparations contained 15% to 25% monocytes, the rest being lymphocytes. In some experiments PBMCs were further fractionated by adherence to gelatidplasma-coated flasks as de~cribed.~' The isolated monocytes were washed with RPM1 medium without serum. The purified monocyte preparation contained 85% to 95% monocytes. The contaminating lymphocytes included 1% to 6% T cells (based on CD3 antigen), 1% to 2% B cells (CD20'), and 3% to 10% non-T, non-B (natural killer [NK]) cells.
For experimentation the PBMCs (2 X 106/mL,), or purified monocytes (5 X 105/mL), were incubated in 1 mL Dulbecco's modified Eagle medium containing 25 mmoVL HEPES, with or without 20% FBS, at 3 7 T , 5% CO2 for 4 hours, unless otherwise indicated. After incubation the cells and media were separated by centrifugation. The cells were washed with Tris-NaC1 buffer (0.1 mom Tris, 0.15 mol/ L NaCI, 0.1 % bovine serum albumin, pH 7.4) then lysed in the same buffer by adding 15 mmoVL n-octyl-beta-D-glycopyranoside at 37°C for 30 minutes.32
Assay of TF Activity
Principle. Total cellular TF activity was determined in the PBMC lysate using a two-stage amidolytic assay, similar to that described earlier by Moore et al." In the first stage, PBMC lysate was mixed with factor VI1 and factor X to combine TF with factor VII, which in turn activated factor X. In the second stage the activity of factor Xa was measured using a chromogenic peptide substrate. Previous activation of factor VI1 by preincubation with low amounts of factor Xa34 did not influence the result of the assay (data not shown). This can be explained by the inherent activity of the factor VI1 zymogen' and its rapid activation by factor Xa.35
Procedure. In a 96-well microtiter plate, cell lysate (derived from IO3 to 1 O4 monocytes) or different dilutions of thromboplastin standard (corresponding to 0.1 to 1 pL of stock) were mixed with 24 n g / d factor VI1 and 2.4 pg/mL factor X in a volume of 150 pL buffer (0.1 m o m Tris, 0.15 moVL NaCI, pH 7.4, containing 7 mmoVL CaC12). The mixture was incubated at 22°C for 40 minutes. Then 50 pL of Spectrozyme FXa (synthetic substrate for factor Xa; 2517 1.4 mg1mL) was added and the rate of absorbance increase at 405 nm was measured using a kinetic plate reader (Molecular Devices, Menlo Park, CA).
Evaluation. TF activity was calculated by reference to standard curves obtained with dilutions of thromboplastin in the amidolytic assay. Clotting time was also measured with thromboplastin according to insert instructions, and a clotting time of 50 seconds was arbitrarily defined as 1,000 mU of TF, following the practice of other in~estigators.~~~~'~.'' As shown in Table 1 , amidolytic (Xa) activity required the addition of each of factors VI1 and X, as well as a source of TF such as rabbit brain thromboplastin or PBMC lysate. Figure 1A shows that factor Xa activity remained constant during the assay, ie, optical density (OD) 405 nm increased linearly with time. The rate of absorbance increase was directly proportional to the amount of added thromboplastin or PBMC lysate (Fig 1 B) . The detection limit was 50 to 100 nL of thromboplastin per well. When compared on the basis of the thromboplastin time standardization procedure, the level of TF activity in LPS-stimulated monocytes measured in this study was in the same order of magnitude as that determined in earlier s t~d i e s .~.~. '~, ' '
Tumor Necrosis Factor (TNF) Assay
The supernatant of PBMCs was assayed for TNF by ELISA (T Cell Sciences, Cambridge, MA).
Analysis of mRNA Expression by Polymerase Chain Reaction (PCR)
Human PBMCs were incubated as described above. The incubation was terminated at 2 hours by adding 3 mL ice-cold phosphatebuffered saline (PBS) and centrifugation at 4°C. Total RNA was prepared from the pelleted cells using a kit (Strategene, La Jolla, CA), based on the method of Chomczynski and S a~c h i .~~ Pelleted cells were lysed with 0.5 mL denaturation solution. RNA was converted into cDNA in a 50-pL reaction mixture containing 500 U of Moloney murine leukemia virus reverse transcriptase (Bethesda Research Laboratories, Gaithersburg, MD) and oligo-dT (Pharmacia LKB, Piscataway, NJ) under the recommended conditions. Primers for TF were synthesized based on the published sequence.37 For TNF and the housekeeping gene G3PDH (glyceraldehyde-3-phosphate dehydrogenase), primers were purchased from Clontech (Palo Alto, CA). Amplification was performed with 1 pL cDNA in 20-pL reaction mixtures containing 10 mmol/L Tris-HCI, pH 8.8, 50 mmol/L KCI, 1.8 mmolL MgCI2, 0.1% Triton X-100, 0.2 mmol/L dNTPs, 0.5 pmol/L of each primer, 0.2 U Taq polymerase, and 250,000 cpm of one '*P end-labeled primer. The mixtures were assembled on ice, then denatured at 94°C (20 seconds), and cycled at 94.5"C (20 seconds), 60°C (30 seconds), 72°C (60 seconds) for 20 to 22 cycles (Gene Amp PEC 9600 thermocycler; Perkin-Elmer, Norfolk, CT). Amplified products were separated by size on a 6% polyacrylamide gel, and quantitated using a Phospho-Imager (Molecular Dynamics, Sunnyvale, CA).
Calculations and Statistical Analysis
Curve fitting was performed by nonlinear least squares method using the GraFit computer program (Erithacus Software Ltd, Staines, UK). All experiments were conducted at least three times, and representative results are depicted, or results are expressed as means t SE, as indicated. Statistical significance was calculated using the unpaired Student's t-test.
RESULTS
Induction o f TF by LPS: Dependence on Serum or LBP
The time course of the induction of tissue factor activity in PBMCs was determined as shown in Fig 2A. PBMCs were incubated with 30 pg/mL E coli 0113 LPS in the presence of 20% FBS. After a lag period of about 2 hours, TF activity rapidly increased between 3 and 5 hours, followed by a slower increase between 5 and 7 hours. The kinetics of the release of TNF was similar (Fig 2B) . The time course of expression did not change at higher LPS concentrations (data not shown). The subsequent experiments were terminated at 4 hours. Under these conditions LPS was a very potent inducer (Fig 3) : TF activity, as well as the release of TNF, was induced by as little as 10 pg/mL LPS in the presence of 20% FBS. Figure 3 also shows that LPS was much less effective in the absence of serum; about a thousand times more LPS (2 ng/mL) was required to induce tissue factor and TNF in the absence of serum. The purified monocyte preparation (see Materials and Methods) responded to LPS similarly as the PBMCs did. In the experiment shown in Fig 4, both purified monocytes (86%) and the parent PBMC preparation (15% monocytes) required serum to produce tissue factor activity in response to low amounts of LPS.
The LPS-potentiating effect of serum was reproduced by the addition of human recombinant LBP (Fig 5) . Human PBMCs were incubated with various concentrations of rLBP. was needed to achieve a stimulation equal to that caused by 20% serum. However, at 1 , O O O pg/mL LPS, 0.02 pg/mL of rLBP exerted maximum potentiation, equal to the effect of 20% serum. The effect of rLBP on the release of TNF was similar (Fig 5B) . At 100 pg/mL LPS, the effect of 20% serum was similar to that of 2 pg/mL of rLBP. At 1, OOO pg/ mL LPS, maximum stimulation of TNF release was achieved by about 0.2 pg/mL of rLBP.
Dependence of TF Induction on CD14
To determine whether these effects of LPS are mediated by the CD14 antigen present on the surface of monocytes, antibodies to this determinant were included in the incubation mixtures containing either rLBP or serum. Figure 6 shows that in the presence of 1 pg/mL rLBP, anti-CD14 MoAbs inhibited the induction of both TF and TNF in a dose-dependent manner. The irrelevant antibody, used as an isotype control, had no effect. Likewise, LPS up to 100 pg/ mL failed to induce TF or TNF in a serum-containing system in the presence of 1 pg/mL anti-CD14 antibody (Fig 7) .
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Effect of rBP123 on the Induction of TF by LPS in the Presence of rLBP
The anti-LPS effect of rBPIZ3 was tested in a serum-free system containing various concentrations of recombinant human LBP. TF activity and TNF production were induced with 130 pg/mL of LPS, in the presence of different concentrations of rBPIz3 (Fig 8) . TF activity and TNF increased with the concentration of rLBP, as shown above (Fig 5) .
The induction of both factors was counteracted by rBPIZ3. Figure 8 shows that the inhibition exerted by rBPIZ3 was dependent on the concentration of rLBP. While 2 pg/mL of rBPIZ3 caused almost 100% inhibition at all rLBP concentrations, the inhibitory effect of lesser amounts of rBPIZ3 decreased with increasing rLBP concentration, suggesting a competition between rLBP and rBPIz3 for binding to LPS. The induction of TF was less sensitive to the inhibitory effect of rBPIz3 than that of TNF, eg, at 2 pg/mL rLBP, TF activity was hardly affected by 0.02 pg/mL of rBPIZ3 (Fig 8A) , whereas TNF production of the same cells was inhibited by 50% ( Fig 8B) .
Effect of rBPI,, on the Induction of TF by LPS in the Presence of FBS
The anti-LPS activity of rBPIZ3 was investigated in the presence of 20% FBS. This experiment was designed to establish the LPS-sensitivity of human monocytes as well as the LPS-antagonizing ability of rBPIz3. Therefore, this experiment was performed using PBMCs from five different donors. Figure 9A shows the induction of TF activity by LPS. Under these conditions, the LPS concentration causing half-maximal TF induction was calculated as 18 -+ 4 pg/mL. rBPIZ3 at both 2 pglmL and 5 pg/mL decreased the induction of TF at all LPS concentrations tested (P < .05). Thaumatin, a protein with similar isoelectric point and molecular size to rBPIZ3, was used as control. As shown in Fig 9A, thaumatin did not interfere with the induction of TF.
TNF was assayed in the supernatant of PBMCs, and showed a similar response to LPS (Fig 9B) . However, the LPS concentration causing half-maximal TNF production was calculated as 110 t_ 26 pg/mL, significantly higher than that calculated for TF expression (P < .05). rBPIZ3 (2 or 5 pgl mL) caused statistically significant decreases in the release of TNF at all LPS concentrations ( P < .05), whereas thaumatin did not affect TNF production.
Effect of rBPIZ3 on the LPS-Induced Expression of mRhTA for TF
To explore the mechanism of the inhibitory action of rBPIZ3, the expression of mRNA for TF and TNF, as well as that of a housekeeping gene (glyceraldehyde-3-phosphate dehydrogenase, G3PDH) was determined using a PCR-based assay. The cells were incubated and stimulated by LPS as described in the preceding experiment, but incubation was terminated at 2 hours, and cellular RNA processed as described in Materials and Methods. As shown in Fig 10, LPS induced the expression of TF mRNA and TNF mRNA in PBMCs in a concentration-dependent manner. In agreement with the results on TF activity (Fig 9A) , mRNA for TF was readily detectable after induction with as little as 10 to 30 pg/mL LPS. Figures 10B and 1OC show that rBPIu (5 pgl mL) greatly decreased the level of mRNA for both TF and TNF. In contrast, neither LPS nor rBPI23 affected the expression of the housekeeping gene for G3PDH (Fig 10A) . The control protein, thaumatin, did not influence the expression of any mRNA (data not shown).
Effects of LBP, Anti-CD14 Antibodies, and BPI on the Induction of TF in the Purified Monocyte Preparation
The effects of the agents influencing LPS recognition were also investigated using the monocyte fraction of PBMCs. The results in Fig 11A show that, in the absence of serum, LBP potentiated the effect of LPS. Anti-CD14 antibodies, as well as rBP123, inhibited the induction of TF. and BPI were also inhibitory in the presence of serum ( Fig  11B) . Thus, the recognition of LPS by purified monocytes required serum or LBP, and the presence of CD14 receptors on the cell surface. BPI inhibited the induction of TF by LPS.
The effects of LBP, anti-CD14 antibodies, and rBPIz3 on monocytes were qualitatively and quantitatively similar to the responses observed with PBMC preparations. These findings indicate that the presence of lymphocytes did not influence the behavior of monocytes in the PBMC preparations.
Induction of TF by Zymosan in the Presence of rBPIZ3
Zymosan is a particulate preparation of yeast cell wall, which is taken up by phagocytic cells. Phagocytosis is known to activate various monocyte functions. To determine if the inhibitory effect of rBPIZ3 was specific for LPS, zymosan was used to induce TF and TNF release (Fig 12) . Zymosan at various concentrations was incubated with PBMCs from multiple donors in the presence of 20% FBS. Zymosan induced the appearance of TF activity and the release of TNF in a dose-dependent manner. However, 5 kg/mL rBPIv did not interfere with the induction of either TF activity, or TNF release (Fig 12) . The increased expression of the corresponding mRNAs was not affected by rBPIZ3 either (data not shown).
DISCUSSION
The results of this study establish the involvement of LBP and CD14 in the mechanism of TF induction by LPS in peripheral blood monocytes, and show the potent inhibitory effect of rBPIzs on that process. TF activity was determined by using a kinetic amidolytic assay for activated factor X, which was shown to be sensitive and specific for TF. While earlier studies used a single, high concentration of LPS,7.* titration of LPS in the present experiments showed that, in the presence of 20% FBS, half-maximal stimulation was caused by as little as 18 pg/mL LPS. The production of TNF (determined in the supernatant of cell cultures) was induced by somewhat higher concentrations of LPS; 110 pg/mL caused half-maximal stimulation. Thus, LPS concentrations in the range of those found in the plasmdserum of septic patients (5 to 500 ~g / m L )~~. '~ elicit the production of both TF and TNF in monocytes.
The concentration of LPS necessary to induce tissue factor activity was about 3 orders of magnitude lower in the presence of serum than that needed in the absence of serum. Addition of rLBP to serum-free systems restored the potency of LPS. The LPS-potentiating effect of 1 to 2 pg/mL rLBP was similar to that of 20% FBS. Furthermore, the induction of tissue factor by LPS was prevented or markedly inhibited by anti-CD14 antibodies. Anti-CD14 also blocked induction in a serum-free, rLBP-containing system; thus, the effect of LPS was dependent on CD14 determinants on the surface of the monocytes, and not on serum-derived sCD14. In agreement with earlier studies, the production of TNF showed a similar dependence on CD14 and LBP.'2,'5,4" This is the first demonstration that the mechanism of the TF-inducing effect of LPS also involves LBP and CD14.
Recognition of LPS in PBMCs and in monocyte preparations purified by adhesion was qualitatively and quantitatively similar (Figs 4 and 12) . There was no indication of a requirement for an excess of T lymphocytes, contrary to some earlier report^."^"^ The inhibitory effect of anti-CD14 antibodies (Figs 6,7, and 11 ) also indicate that the monocyte is the LPS-responsive cell, because no other leukocyte expresses appreciable amounts of CD14.43 Furthermore, monocytes are the only blood cells known to express TF after tim mu la ti on.^^*^"^ In agreement with our results, recent studies have also shown LPS induction of TF in adherent monocytes, as well as in the monocytic cell line THP-1.9"' Induction of TF activity by LPS was inhibited by rBPIz3 in the presence of either serum or rLBP. The induction of TNF production was also inhibited, in agreement with an earlier rep0rt.2~ In addition, the present study shows that the expression of mRNA for both TF and TNF was inhibited by rBPIZ3. The latter result indicates that rBPIz3 interferes with the induction mechanism proximal to transcription. The specificity of the inhibitory effect of rBPIz3 toward LPS was demonstrated by the inability of rBPIz3 to inhibit zymosaninduced increase in TF activity and TNF production. The expression of a housekeeping gene, G3PDH, was not affected, either. Thus, rBPIz3 did not interfere with the ability of monocytes to express either of these products, rather it specifically prevented LPS from exerting its stimulatory effect. The extent of inhibition depended on the relative concentrations of rLBP and rBPIz3 (see Fig 8) . indicating competition between these proteins for binding to LPS. This competitive inhibition of LPS function is in agreement with a recent report on competition between rBPIZ3 and LBP for LPS binding to monocytes. 46 These results suggest a common mechanism by which LPS induces the expression of TF and TNF, and this mechanism involves CD14 and LBP. Furthermore, rBPIz3 inhibits the induction of TF and TNF in a similar fashion. Nevertheless, there were some quantitative differences between the TF and TNF responses. The induction of TF needed less LPS than that of TNF. It was also noted that the inhibitory effect of rBPIz3 was invariably greater on TNF production than on TF activity, in the presence of both serum and rLBP. The difference between the inhibition of TF and TNF expression by rBPIZ3 may be due to the lower LPS requirement of TF induction. (Considering an equilibrium between free rBPIZ3, free LPS, and BPI,,-LPS complexes, low concentrations of free LPS represent relatively larger stimuli for the induction of tissue factor than for that of TNF.) Because the difference between the induction of TF and TNF by LPS was also demonstrated at the level of mRNAs, the regulation of the respective mRNA concentrations are likely to differ."
The pathophysiologic consequences of aberrant TF expression have recently been recognized in Gram-negative sepsis, which is frequently accompanied by DIC.3-6 In meningococcal disease, which is characterized by very high levels of endotoxin in the blood plasma (>IO ng/mL) and DIC,47 circulating monocytes exhibit increased procoagulant activit^.^ The high sensitivity of monocytes to LPS in the presence of LBP or serum suggests that these cells may also initiate aberrant coagulation in patients with relatively modest levels of endotoxemia. Furthermore, TF activity induced in endothelial cells by TNF and interle~kin-l/3~* (released by LPSstimulated mononuclear phagocytes) is also considered to contribute to the development of DIC in Gram-negative sepsis. Endotoxin-induced hypercoagulability has been decreased by monoclonal antibodies against the factor VIIa-TF complex.49 Conversely, rabbits depleted of TF pathway inhibitor are more sensitive to the lethal effects of LPS.34 The LPS-antagonizing properties of rBPIZ3, which include the inhibition of the induction of both TF and proinflammatory cytokines, suggest that rBPIZ3 may be a novel therapeutic in Gram-negative sepsis for the prevention of DIC.
